Synthesis and properties of the weakly coordinating anion [Me3 NB12 Cl11 ](-). PMID: 25196859
Healthy adult gut microbiota sustains its own vitamin B12 requirement in an in vitro batch fermentation model. PMID: 36532531
Development of protective agent against Hottentotta saulcyi venom using camelid single-domain antibody. PMID: 26468036
Functional MXene Materials: Progress of Their Applications. PMID: 30047591
Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSV. PMID: 23254370
Nanobody‑horseradish peroxidase and -EGFP fusions as reagents to detect porcine parvovirus in the immunoassays. PMID: 31910833
Sindbis virus attachment: isolation and characterization of mutants with impaired binding to vertebrate cells. PMID: 7684466
In Vitro Transfection of Up-Regulated Genes Identified in Favorable-Outcome Neuroblastoma into Cell Lines. PMID: 36231133
Regulation of Vibrio anguillarum empA metalloprotease expression and its role in virulence. PMID: 15240301
Vitamin B12 transport proteins in patients with HIV-1 infection and AIDS. PMID: 8349197
Influenza B virus NB glycoprotein is a component of the virion. PMID: 8661386
A Nonstoichiometric Niobium Oxide/Graphite Composite for Fast-Charge Lithium-Ion Batteries. PMID: 35618443
Reproducible pneumonia in gnotobiotic piglets induced with broth cultures of Mycoplasma hyopneumoniae and the effect of animal passage on virulence. PMID: 6718814
Activation of CS2 and CO2 by Silylium Cations. PMID: 33215771
Simultaneous Large Optical and Piezoelectric Effects Induced by Domain Reconfiguration Related to Ferroelectric Phase Transitions. PMID: 34773926
The Me3 NB12 Cl11. Radical: A Strong One-Electron Oxidizing Agent. PMID: 27704626
On the Microstructure and Properties of Nb-12Ti-18Si-6Ta-5Al-5Cr-2.5W-1Hf (at.%) Silicide-Based Alloys with Ge and Sn Additions. PMID: 32842708
Synthesis, biological evaluation and molecular docking studies of novel 3,5-disubstituted 2,4-thiazolidinediones derivatives. PMID: 31129500
Achieving Giant Piezoelectricity and High Property Uniformity Simultaneously in a Relaxor Ferroelectric Crystal through Rare-Earth Element Doping. PMID: 36285669
A large copper-niobate cluster with the pagoda-shaped subunit {Nb20O59}. PMID: 33885695
QSAR, docking, ADMET, and system pharmacology studies on tormentic acid derivatives for anticancer activity. PMID: 28705120
Nb12 +-niobespherene: a full-metal hollow-cage cluster with superatomic stability and resistance to CO attack. PMID: 37035019
Embonic Acid Functionalized Niobium Complexes with Selective Dye Sorption Properties. PMID: 29608066
Effect of the medium on intramolecular H-atom tunneling: cis-trans conversion of formic acid in solid matrixes of noble gases. PMID: 21141902
Electronic structures, vibrational and thermochemical properties of neutral and charged niobium clusters Nb(n), n = 7-12. PMID: 21446686
Superconducting current path and flux line shape in NbTiTa obtained by inter-diffusion process. PMID: 21693860
A Luminescence-Based Method for In Vitro Screening of Immunomodulatory Checkpoints and Therapeutics., PMID:40402459
Immunization with recombinant HPV16-E7d in fusion with Flagellin as a cancer vaccine: Effect of antigen-adjuvant orientation on the immune response pattern., PMID:39939497
Development and evaluation of a novel E7 multi-epitopic vaccine for human papillomavirus type 16: design, expression, purification, and immunological characterization., PMID:39910471
HPV16 mutant E6/E7 construct is protective in mouse model., PMID:39350162
MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2., PMID:38461243
Evaluation of HPV 16 and HPV 18 Oncoprotein Expression as Alternative Diagnostic Tools in Cervical Lesion., PMID:38415538
A Therapeutic DNA Vaccine Targeting HPV16 E7 in Combination with Anti-PD-1/PD-L1 Enhanced Tumor Regression and Cytotoxic Immune Responses., PMID:37895145
Skin-Grafting and Dendritic Cell "Boosted" Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines., PMID:37626903
A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for in vitro screening of immunomodulatory checkpoints and therapeutics., PMID:37559730
HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women., PMID:35351184
Immunohistochemical Detection of Human Papillomavirus 16 E7 Oncoprotein in Cervical Lesions., PMID:34729114
Targeting Human Papillomavirus-Associated Cancer by Oncoprotein-Specific Recombinant Antibodies., PMID:34502053
Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers., PMID:34432728
Antigen Delivery to DEC205+ Dendritic Cells Induces Immunological Memory and Protective Therapeutic Effects against HPV-Associated Tumors at Different Anatomical Sites., PMID:34345218
Serum HPV16 E7 Oncoprotein Is a Recurrence Marker of Oropharyngeal Squamous Cell Carcinomas., PMID:34282779
Enhancing immunogenicity of HPV16 E7 DNA vaccine by conjugating codon-optimized GM-CSF to HPV16 E7 DNA., PMID:34247810
Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer., PMID:33949155
ePCL Electrospun Microfibrous Layers for Immune Assays: Sensitive ELISA for the Detection of Serum Antibodies Against HPV16 E7 Oncoprotein., PMID:33842749
Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model., PMID:33627686
Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors., PMID:33485370
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody., PMID:33468698
Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens., PMID:33335126
PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model., PMID:33108473
A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)., PMID:32918586
Epitope Mapping and Computational Analysis of Anti-HPV16 E6 and E7 Antibodies in Single-Chain Format for Clinical Development as Antitumor Drugs., PMID:32640530
A preliminary study on the immune responses of HPV16-E7 by combined intranasal immunization with lymphotoxin., PMID:32627150
Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine., PMID:32554612
Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18., PMID:32214362
Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies., PMID:32204370
Antibodies against human papillomavirus proteins in Barrett's dysplasia and intramucosal esophageal adenocarcinoma., PMID:32170783
A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer., PMID:32151670
Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment., PMID:32111835
CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies., PMID:31964784
FLT3L and granulocyte macrophage colony-stimulating factor enhance the anti-tumor and immune effects of an HPV16 E6/E7 vaccine., PMID:31881013
The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells., PMID:31806970
TCR sequencing paired with massively parallel 3' RNA-seq reveals clonotypic T cell signatures., PMID:31745340
A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3., PMID:31576684
Prognostic value of posttreatment HPV-specific antibodies in patients with oropharyngeal tumors., PMID:30986340
Post-treatment human papillomavirus antibody kinetics in cervical cancer patients., PMID:30955486
Nanobody against the E7 oncoprotein of human papillomavirus 16., PMID:30849663
Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women., PMID:30755156
Extracellular overproduction of E7 oncoprotein of Iranian human papillomavirus type 16 by genetically engineered Lactococcus lactis., PMID:30678667
Increased Response of Human T-Lymphocytes by Dendritic Cells Pulsed with HPV16E7 and Pleurotus sajor-caju-β-glucan (PBG)., PMID:30593739
Nuclear lactate dehydrogenase A senses ROS to produce α-hydroxybutyrate for HPV-induced cervical tumor growth., PMID:30356100
Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer., PMID:30353680
Oral immunization with recombinant Lactococcus lactis NZ9000 expressing human papillomavirus type 16 E7 antigen and evaluation of its immune effects in female C57BL/6 mice., PMID:30192395
Small Heat Shock Proteins B1 and B6: Which One is the Most Effective Adjuvant in Therapeutic HPV Vaccine?, PMID:30171788
Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice., PMID:30131378
Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers., PMID:30054333
A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer., PMID:30026865
For research use only. Not for human or drug use.
